679 related articles for article (PubMed ID: 32409518)
1. Impact of skin, musculoskeletal and psychosocial aspects on quality of life in psoriatic arthritis patients: A cross-sectional study of outpatient clinic patients in the biologic treatment era.
Haugeberg G; Michelsen B; Kavanaugh A
RMD Open; 2020 May; 6(1):. PubMed ID: 32409518
[TBL] [Abstract][Full Text] [Related]
2. Need for Improvement in Current Treatment of Psoriatic Arthritis: Study of an Outpatient Clinic Population.
Michelsen B; Diamantopoulos AP; Høiberg HK; Soldal DM; Kavanaugh A; Haugeberg G
J Rheumatol; 2017 Apr; 44(4):431-436. PubMed ID: 28148701
[TBL] [Abstract][Full Text] [Related]
3. Perceived influence of health status on sexual activity in patients with psoriatic arthritis.
Haugeberg G; Michelsen B; Østensen M; Kavanaugh A
Scand J Rheumatol; 2020 Nov; 49(6):468-475. PubMed ID: 32669024
[No Abstract] [Full Text] [Related]
4. Relationship of pain and fatigue with health-related quality of life and work in patients with psoriatic arthritis on TNFi: results of a multi-national real-world study.
Conaghan PG; Alten R; Deodhar A; Sullivan E; Blackburn S; Tian H; Gandhi K; Jugl SM; Strand V
RMD Open; 2020 Jun; 6(2):. PubMed ID: 32611650
[TBL] [Abstract][Full Text] [Related]
5. Exploring 5-year changes in general and skin health-related quality of life in psoriatic arthritis patients.
Wilk M; Michelsen B; Łosińska K; Kavanaugh A; Korkosz M; Haugeberg G
Rheumatol Int; 2024 Apr; 44(4):675-685. PubMed ID: 38319377
[TBL] [Abstract][Full Text] [Related]
6. Association Between Comorbidities and Quality of Life in Psoriatic Arthritis: Results from a Multicentric Cross-sectional Study.
Bavière W; Deprez X; Houvenagel E; Philippe P; Deken V; Flipo RM; Paccou J
J Rheumatol; 2020 Mar; 47(3):369-376. PubMed ID: 31203223
[TBL] [Abstract][Full Text] [Related]
7. Psoriatic arthritis: exploring the occurrence of sleep disturbances, fatigue, and depression and their correlates.
Haugeberg G; Hoff M; Kavanaugh A; Michelsen B
Arthritis Res Ther; 2020 Aug; 22(1):198. PubMed ID: 32847612
[TBL] [Abstract][Full Text] [Related]
8. Clinical and Patient-reported Outcomes in Patients with Psoriatic Arthritis (PsA) by Body Surface Area Affected by Psoriasis: Results from the Corrona PsA/Spondyloarthritis Registry.
Mease PJ; Karki C; Palmer JB; Etzel CJ; Kavanaugh A; Ritchlin CT; Malley W; Herrera V; Tran M; Greenberg JD
J Rheumatol; 2017 Aug; 44(8):1151-1158. PubMed ID: 28620063
[TBL] [Abstract][Full Text] [Related]
9. Results of a global, patient-based survey assessing the impact of psoriatic arthritis discussed in the context of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire.
Coates LC; Orbai AM; Azevedo VF; Cappelleri JC; Steinberg K; Lippe R; Lim I; Eder L; Richette P; Weng MY; Queiro Silva R; Fallon L
Health Qual Life Outcomes; 2020 Jun; 18(1):173. PubMed ID: 32513190
[TBL] [Abstract][Full Text] [Related]
10. Enthesitis and its relationship with disease activity, functional status, and quality of life in psoriatic arthritis: a multi-center study.
Sunar I; Ataman S; Nas K; Kilic E; Sargin B; Kasman SA; Alkan H; Sahin N; Cengiz G; Cuzdan N; Gezer IA; Keskin D; Mülkoğlu C; Resorlu H; Bal A; Duruöz MT; Küçükakkaş O; Yurdakul OV; Melikoglu MA; Aydın Y; Ayhan FF; Bodur H; Calis M; Capkın E; Devrimsel G; Gok K; Hizmetli S; Kamanlı A; Keskin Y; Kocabas H; Kutluk O; Şen N; Şendur OF; Tekeoğlu I; Tolu S; Toprak M; Tuncer T
Rheumatol Int; 2020 Feb; 40(2):283-294. PubMed ID: 31773391
[TBL] [Abstract][Full Text] [Related]
11. Essential factors influencing health-related-quality of life in psoriasis.
Rønneberg Mehren C; Clemmensen A; Boe-Hansen Dall A; Philipsen P; Gniadecki R
J Drugs Dermatol; 2014 Mar; 13(3):246-50. PubMed ID: 24595566
[TBL] [Abstract][Full Text] [Related]
12. The psychosocial burden of psoriatic arthritis.
Husni ME; Merola JF; Davin S
Semin Arthritis Rheum; 2017 Dec; 47(3):351-360. PubMed ID: 28802776
[TBL] [Abstract][Full Text] [Related]
13. Patients with psoriatic arthritis have worse quality of life than those with psoriasis alone.
Rosen CF; Mussani F; Chandran V; Eder L; Thavaneswaran A; Gladman DD
Rheumatology (Oxford); 2012 Mar; 51(3):571-6. PubMed ID: 22157469
[TBL] [Abstract][Full Text] [Related]
14. Treatment patterns, unmet need, and impact on patient-reported outcomes of psoriatic arthritis in the United States and Europe.
Gottlieb A; Gratacos J; Dikranian A; van Tubergen A; Fallon L; Emir B; Aikman L; Smith T; Chen L
Rheumatol Int; 2019 Jan; 39(1):121-130. PubMed ID: 30426237
[TBL] [Abstract][Full Text] [Related]
15. Impact of biologic DMARDs on quality of life: 12-month results of a rheumatic diseases cohort using the Brazilian EQ-5D tariff.
Alves de Oliveira Junior H; Pereira da Veiga T; Acurcio FA; Almeida AM; Ribeiro Dos Santos JB; da Silva MRR; Kakehasi AM; Cherchiglia ML
Hosp Pract (1995); 2020 Oct; 48(4):213-222. PubMed ID: 32567403
[TBL] [Abstract][Full Text] [Related]
16. Minimal disease activity and impact of disease in psoriatic arthritis: a Spanish cross-sectional multicenter study.
Queiro R; Cañete JD; Montilla C; Abad M; Montoro M; Gómez S; Cábez A;
Arthritis Res Ther; 2017 Mar; 19(1):72. PubMed ID: 28356155
[TBL] [Abstract][Full Text] [Related]
17. Determinants of Patient-Reported Psoriatic Arthritis Impact of Disease: An Analysis of the Association With Sex in 458 Patients From Fourteen Countries.
Orbai AM; Perin J; Gorlier C; Coates LC; Kiltz U; Leung YY; Palominos PE; Cañete JD; Scrivo R; Balanescu A; Dernis E; Tälli S; Ruyssen-Witrand A; Soubrier M; Aydin S; Eder L; Gaydukova I; Lubrano E; Kalyoncu U; Richette P; Husni ME; Smolen JS; de Wit M; Gossec L
Arthritis Care Res (Hoboken); 2020 Dec; 72(12):1772-1779. PubMed ID: 31609525
[TBL] [Abstract][Full Text] [Related]
18. Adalimumab improves joint-related and skin-related functional impairment in patients with psoriatic arthritis: patient-reported outcomes of the Adalimumab Effectiveness in Psoriatic Arthritis Trial.
Gladman DD; Mease PJ; Cifaldi MA; Perdok RJ; Sasso E; Medich J
Ann Rheum Dis; 2007 Feb; 66(2):163-8. PubMed ID: 17046964
[TBL] [Abstract][Full Text] [Related]
19. Gender does not make a difference in "composite psoriatic disease activity index (CPDAI)" in patients with psoriatic arthritis.
Kenar G; Yarkan H; Zengin B; Can G; Birlik M; Önen F
Rheumatol Int; 2018 Nov; 38(11):2069-2076. PubMed ID: 30194455
[TBL] [Abstract][Full Text] [Related]
20. Humanistic and Economic Impact of Moderate to Severe Plaque Psoriasis in Brazil.
Lopes N; Dias LLS; Azulay-Abulafia L; Oyafuso LKM; Suarez MV; Fabricio L; Kobata CM; Cestari T; Gontijo B; Sabbag CY; Antonio JR; Romiti R; Pertel PC
Adv Ther; 2019 Oct; 36(10):2849-2865. PubMed ID: 31432463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
